Epicardial fat accumulation, cardiometabolic profile and cardiovascular events in patients with stages 3-5 chronic kidney disease

Journal of Internal Medicine

Volumn 278, Issue 1, 2015, Pages 77-87

  Cordeiro, Antonio C ^a,b   Amparo, F C ^b   Oliveira, M A C ^b   Amodeo, C ^b   Smanio, P ^b   Pinto, I M F ^b   Lindholm, B ^a   Stenvinkel, P ^a   Carrero, J J ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

Author keywords

Obesity; Outcomes; Pericardial fat; Renal disease; Uraemia

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CALCITRIOL; CALCIUM ION; CHOLESTEROL; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEPTIN; PARATHYROID HORMONE; PHOSPHORUS; TRIACYLGLYCEROL; VITAMIN D;

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY CALCIFICATION; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; EPICARDIAL ADIPOSE TISSUE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE ISCHEMIA; HUMAN; INTRAABDOMINAL FAT; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; ABDOMINAL FAT; ADIPOSITY; CARDIOVASCULAR DISEASES; COMPLICATION; CROSS-SECTIONAL STUDIES; HUMANS; METABOLISM; MIDDLE AGED; PERICARDIUM; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

ABDOMINAL FAT; ADIPOSE TISSUE; ADIPOSITY; AGED; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PERICARDIUM; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 84930931034     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/joim.12344     Document Type: Article

References (60)

1. Gelber RP, Kurth T, Kausz AT et al. Association between body mass index and CKD in apparently healthy men. Am J Kidney Dis 2005; 46: 871-80.
2. Carrero JJ, Avesani CM. Pros and cons of body mass index as a nutritional and risk assessment tool in dialysis patients. Semin Dial 2014; doi: 10.1111/sdi.12287. [Epub ahead of print].
3. Stenvinkel P, Zoccali C, Ikizler TA. Obesity in CKD-what should nephrologists know? J Am Soc Nephrol 2013; 24: 1727-36.
4. Unger RH, Scherer PE. Gluttony, sloth and the metabolic syndrome: a roadmap to lipotoxicity. Trends Endocrinol Metab 2010; 21: 345-52.
5. Carrero JJ, Cordeiro AC, Lindholm B, Stenvinkel P. The emerging pleiotrophic role of adipokines in the uremic phenotype. Curr Opin Nephrol Hypertens 2010; 19: 37-42.
6. Witasp A, Carrero JJ, Heimburger O et al. Increased expression of pro-inflammatory genes in abdominal subcutaneous fat in advanced chronic kidney disease patients. J Intern Med 2011; 269: 410-9.
7. Carvalho LK, Barreto Silva MI, da Silva Vale B et al. Annual variation in body fat is associated with systemic inflammation in chronic kidney disease patients Stages 3 and 4: a longitudinal study. Nephrol Dial Transplant 2012; 27: 1423-8.
8. Miyamoto T, Rashid Qureshi A, Heimburger O et al. Inverse relationship between the inflammatory marker pentraxin-3, fat body mass, and abdominal obesity in end-stage renal disease. Clin J Am Soc Nephrol 2011; 6: 2785-91.
9. Gotoh H, Gohda T, Tanimoto M, Gotoh Y, Horikoshi S, Tomino Y. Contribution of subcutaneous fat accumulation to insulin resistance and atherosclerosis in haemodialysis patients. Nephrol Dial Transplant 2009; 24: 3474-80.
10. Odamaki M, Furuya R, Ohkawa S et al. Altered abdominal fat distribution and its association with the serum lipid profile in non-diabetic haemodialysis patients. Nephrol Dial Transplant 1999; 14: 2427-32.
11. Ramos LF, Shintani A, Ikizler TA, Himmelfarb J. Oxidative stress and inflammation are associated with adiposity in moderate to severe CKD. J Am Soc Nephrol 2008; 19: 593-9.
12. Cordeiro AC, Qureshi AR, Lindholm B et al. Visceral fat and coronary artery calcification in patients with chronic kidney disease. Nephrol Dial Transplant 2013; 28(Suppl 4): iv152-9.
13. Witasp A, Carrero JJ, Hammarqvist F et al. Expression of osteoprotegerin in human fat tissue; implications for chronic kidney disease. Eur J Clin Invest 2011; 41: 498-506.
14. Cordeiro AC, Qureshi AR, Stenvinkel P et al. Abdominal fat deposition is associated with increased inflammation, protein-energy wasting and worse outcome in patients undergoing haemodialysis. Nephrol Dial Transplant 2010; 25: 562-8.
15. Kamimura MA, Carrero JJ, Canziani ME, Watanabe R, Lemos MM, Cuppari L. Visceral obesity assessed by computed tomography predicts cardiovascular events in chronic kidney disease patients. Nutr Metab Cardiovasc Dis 2013; 23: 891-7.
16. Postorino M, Marino C, Tripepi G, Zoccali C. Abdominal obesity and all-cause and cardiovascular mortality in end-stage renal disease. J Am Coll Cardiol 2009; 53: 1265-72.
17. Iacobellis G, Corradi D, Sharma AM. Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med 2005; 2: 536-43.
18. Corradi D, Maestri R, Callegari S et al. The ventricular epicardial fat is related to the myocardial mass in normal, ischemic and hypertrophic hearts. Cardiovasc Pathol 2004; 13: 313-6.
19. Shirani J, Berezowski K, Roberts WC. Quantitative measurement of normal and excessive (cor adiposum) subepicardial adipose tissue, its clinical significance, and its effect on electrocardiographic QRS voltage. Am J Cardiol 1995; 76: 414-8.
20. Baker AR, Silva NF, Quinn DW et al. Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc Diabetol 2006; 5: 1.
21. Kremen J, Dolinkova M, Krajickova J et al. Increased subcutaneous and epicardial adipose tissue production of proinflammatory cytokines in cardiac surgery patients: possible role in postoperative insulin resistance. J Clin Endocrinol Metab 2006; 91: 4620-7.
22. Cheng KH, Chu CS, Lee KT et al. Adipocytokines and proinflammatory mediators from abdominal and epicardial adipose tissue in patients with coronary artery disease. Int J Obes (Lond) 2008; 32: 268-74.
23. Mazurek T, Zhang L, Zalewski A et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 2003; 108: 2460-6.
24. Marchington JM, Mattacks CA, Pond CM. Adipose tissue in the mammalian heart and pericardium: structure, foetal development and biochemical properties. Comp Biochem Physiol B 1989; 94: 225-32.
25. Katsiki N, Mikhailidis DP, Wierzbicki AS. Epicardial fat and vascular risk: a narrative review. Curr Opin Cardiol 2013; 28: 458-63.
26. Turkmen K, Kayikcioglu H, Ozbek O et al. The relationship between epicardial adipose tissue and malnutrition, inflammation, atherosclerosis/calcification syndrome in ESRD patients. Clin J Am Soc Nephrol 2011; 6: 1920-5.
27. Turkmen K, Ozbek O, Kayikcioglu H et al. The relationship between epicardial adipose tissue and coronary artery calcification in peritoneal dialysis patients. Cardiorenal Med 2012; 2: 43-51.
28. Turan MN, Gungor O, Asci G et al. Epicardial adipose tissue volume and cardiovascular disease in hemodialysis patients. Atherosclerosis 2013; 226: 129-33.
29. Erdur MF, Tonbul HZ, Ozbiner H et al. The relationship between atherogenic index of plasma and epicardial adipose tissue in hemodialysis and peritoneal dialysis patients. Ren Fail 2013; 35: 1193-8.
30. Turkmen K, Tonbul HZ, Erdur FM et al. Peri-aortic fat tissue and malnutrition-inflammation-atherosclerosis/calcification syndrome in end-stage renal disease patients. Int Urol Nephrol 2013; 45: 857-67.
31. Turkmen K, Ozbek O, Kayrak M, Samur C, Guler I, Tonbul HZ. Peri-aortic fat tissue thickness in peritoneal dialysis patients. Perit Dial Int 2013; 33: 316-24.
32. Kerr JD, Holden RM, Morton AR et al. Associations of epicardial fat with coronary calcification, insulin resistance, inflammation, and fibroblast growth factor-23 in stage 3-5 chronic kidney disease. BMC Nephrol 2013; 14: 26.
33. Cordeiro AC, Lindholm B, Sousa MG et al. Reliability of electrocardiographic surrogates of left ventricular mass in patients with chronic kidney disease. J Hypertens 2014; 32: 439-45.
34. Chobanian AV, Bakris GL, Black HR et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-52.
35. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-83.
36. Kobold U. Approaches to measurement of vitamin D concentrations - mass spectrometry. Scand J Clin Lab Invest Suppl 2012; 243: 54-9.
37. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990; 15: 827-32.
38. Jain T, Peshock R, McGuire DK et al. African Americans and Caucasians have a similar prevalence of coronary calcium in the Dallas Heart Study. J Am Coll Cardiol 2004; 44: 1011-7.
39. Berman DS, Kiat HS, Van Train KF, Germano G, Maddahi J, Friedman JD. Myocardial perfusion imaging with technetium-99 m-sestamibi: comparative analysis of available imaging protocols. J Nucl Med 1994; 35: 681-8.
40. Hakeem A, Bhatti S, Dillie KS et al. Predictive value of myocardial perfusion single-photon emission computed tomography and the impact of renal function on cardiac death. Circulation 2008; 118: 2540-9.
41. Lang RM, Bierig M, Devereux RB et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18: 1440-63.
42. Zoccali C, Benedetto FA, Mallamaci F et al. Prognostic impact of the indexation of left ventricular mass in patients undergoing dialysis. J Am Soc Nephrol 2001; 12: 2768-74.
43. De Larochelliere E, Cote J, Gilbert G et al. Visceral/epicardial adiposity in nonobese and apparently healthy young adults: association with the cardiometabolic profile. Atherosclerosis 2014; 234: 23-9.
44. Liu X, Post WS, McLenithan J et al. Determinants of intrathoracic adipose tissue volume and associations with cardiovascular disease risk factors in Amish. Nutr Metab Cardiovasc Dis 2014; 24: 286-93.
45. Rosito GA, Massaro JM, Hoffmann U et al. Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study. Circulation 2008; 117: 605-13.
46. Jager KJ, Stel VS, Zoccali C, Wanner C, Dekker FW. The issue of studying the effect of interventions in renal replacement therapy - to what extent may we be deceived by selection and competing risk? Nephrol Dial Transplant 2010; 25: 3836-9.
47. Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 2004; 164: 659-63.
48. Gau S, Klinghammer L, Jahn D, Schuhback A, Achenbach S, Marwan M. Epicardial fat and coronary artery calcification in patients on long-term hemodialysis. J Comput Assist Tomogr 2014; 38: 768-72.
49. Guglielmi V, Maresca L, D'Adamo M et al. Age-related different relationships between ectopic adipose tissues and measures of central obesity in sedentary subjects. PLoS One 2014; 9: e103381.
50. Bazzocchi A, Diano D, Ponti F et al. Health and ageing: a cross-sectional study of body composition. Clin Nutr 2013; 32: 569-78.
51. Takeda A, Toda T, Shinohara S, Mogi Y, Matsui N. Factors contributing to higher hematocrit levels in hemodialysis patients not receiving recombinant human erythropoietin. Am J Kidney Dis 2002; 40: 104-9.
52. Stenvinkel P, Heimburger O, Lonnqvist F, Barany P. Does the ob gene product leptin stimulate erythropoiesis in patients with chronic renal failure? Kidney Int 1998; 53: 1430-1.
53. Ford ES, Ajani UA, McGuire LC, Liu S. Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care 2005; 28: 1228-30.
54. Cheng S, Massaro JM, Fox CS et al. Adiposity, cardiometabolic risk, and vitamin D status: the Framingham Heart Study. Diabetes 2010; 59: 242-8.
55. Gupta GK, Agrawal T, DelCore MG, Mohiuddin SM, Agrawal DK. Vitamin D deficiency induces cardiac hypertrophy and inflammation in epicardial adipose tissue in hypercholesterolemic swine. Exp Mol Pathol 2012; 93: 82-90.
56. Sacks HS, Fain JN. Human epicardial adipose tissue: a review. Am Heart J 2007; 153: 907-17.
57. Baker AR, Harte AL, Howell N et al. Epicardial adipose tissue as a source of nuclear factor-kappaB and c-Jun N-terminal kinase mediated inflammation in patients with coronary artery disease. J Clin Endocrinol Metab 2009; 94: 261-7.
58. Wong CX, Abed HS, Molaee P et al. Pericardial fat is associated with atrial fibrillation severity and ablation outcome. J Am Coll Cardiol 2011; 57: 1745-51.
59. Thanassoulis G, Massaro JM, O'Donnell CJ et al. Pericardial fat is associated with prevalent atrial fibrillation: the Framingham Heart Study. Circ Arrhythm Electrophysiol 2010; 3: 345-50.
60. Wang T, Liu Q, Liu C et al. Correlation of echocardiographic epicardial fat thickness with severity of coronary artery disease in patients with acute myocardial infarction. Echocardiography 2014; 31: 1177-81.